drugset / Trial / NCT01906944

Ultrasound Guided Transversus Abdominis Plane (TAP) vs. Trigger Point Injection (TPI) for Abdominal Wall Pain

NCT01906944

Phase 2 Completed 62 enrolled Mayo Clinic
RandomizedParallel-groupOpen-labelTreatment

Summary

Patients with chronic abdominal pain- with a component of abdominal wall pain- are often treated with trigger point injections. This study will help to determine if a block within the transversus abdominis plane (TAP) will provide superior analgesic benefit to a trigger point injection as therapy for these patients.

Timeline

Start
2012-01
Primary completion
2019-08-18
Completion
2019-08-18

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bupivacaine Other / unclassified 0.25 % Other
Comparator Bupivacaine Other / unclassified 5 ml Other
Comparator Bupivacaine Other / unclassified 10 ml Other
Comparator Triamcinolone Other / unclassified 20 mg Other

Indications

No indication recorded.